Total planned funding: $574,965,803
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $574,965,803 |
Organizational Types
NGO | $155,446,205 |
Private Contractor | $115,059,021 |
Own Agency | $85,831,373 |
Host Country Government Agency | $76,771,959 |
University | $59,483,000 |
Unknown | $56,124,736 |
Parastatal | $10,534,579 |
Other USG Agency | $7,715,479 |
Implementing Agency | $3,653,807 |
FBO | $2,305,644 |
Multi-lateral Agency | $2,040,000 |
Program Areas
Treatment | $173,001,904 |
Prevention | $117,769,864 |
Care | $113,172,886 |
Governance and Systems | $83,816,760 |
Management and Operations | $48,229,131 |
Testing | $38,975,258 |
Budget Codes
HTXS: Treatment: Adult Treatment | $148,454,302 |
HKID: Care: Orphans and Vulnerable Children | $51,141,830 |
HVMS: Management and Operations | $48,229,131 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,309,478 |
HVCT: Testing: HIV Testing and Counseling | $38,975,258 |
OHSS: Health Systems Strengthening | $37,084,379 |
HVSI: Strategic Information | $35,899,758 |
HBHC: Care: Adult Care and Support | $28,036,257 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,414,158 |
HVTB: Care: TB/HIV | $24,559,926 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,862,641 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,919,942 |
PDTX: Treatment: Pediatric Treatment | $14,798,583 |
HLAB: Laboratory Infrastructure | $10,832,623 |
HTXD: Treatment: ARV Drugs | $9,749,019 |
PDCS: Care: Pediatric Care and Support | $9,434,873 |
HMBL: Biomedical Prevention: Blood Safety | $4,260,220 |
HMIN: Biomedical Prevention: Injection Safety | $1,003,425 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$66,021,462
Countries/Regions
University of Washington:
$53,051,142
Countries/Regions
USG Aggregated Agencies:
$48,560,679
Countries/Regions